N/A N=5,392 Impact of Body Weight on the Immediate Health of the Pediatric Population
Childhood Obesity
Primary: Diagnosis of Infectious Disease — 900; 1067 Participants — p=.026
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=28 Increased Monitoring of Physical Activity and Calories With Technology
Weight Change, Body · Behavior, Health · Obesity, Childhood
Primary: BMI Percentile — 98.46; 99.37 BMI percentile for age and sex
N/A N=47 Healthy Bodies, Healthy Kids
Child Mental Disorders · Obesity · Metabolic Syndrome
Primary: DEXA-measured Adiposity — 0.76; -0.43; -2.79 kilograms — p=0.01
Phase 2 N=26 Exenatide in Extreme Pediatric Obesity
Obesity
Primary: Percent Change From Baseline in Body Mass Index at 3-months — -2.9; -0.15 percentage of change in BMI
N/A N=72 For the Health of Our Children--Clinic Based Treatment of Childhood Obesity
Obesity
Primary: Body Mass Index Z-score Change — -0.02; -0.08 BMI z-score change
Phase 2 N=30 Topiramate in Adolescents With Severe Obesity
Obesity, Morbid · Obesity · Weight Loss
Primary: Percent Change From Baseline in Body Mass Index at 28-Weeks — -2.74; -0.85 % change BMI
N/A N=76 Pediatric Quality of Life Among Population With Body Mass Index (BMI) Greater Than or Equal to 85%
Pediatric Obesity
Primary: Change in Child Self-report Health Related Quality of Life Scores After Intervention: Total, Physical and Psychosocial (Presented in This Order) — 7.8; -0.9; 9.1; -0.3…
N/A N=352 Population Effects of MI on Pediatric Obesity in Primary Care
Pediatric Obesity
Primary: Percent Distance From the Sex-age Specific 95th Percentile — 106.4; 102.7 % distance from 95th percentile
Phase 2 N=200 Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases
Diabetes Mellitus · Hypertension · Metabolic Disease
Primary: Change in BMI Standard Deviation Score — -0.12; -0.06 Standard Deviation Score — p=0.007
Phase 2 N=77 Parent-Based Treatment for Pediatric Overweight
Overweight · Obesity
Primary: BMI Z Score — 2.3; 2.4 Z-score
Phase 3 N=80 Propofol in Obese Children
Pharmacodynamics · Obesity
Primary: Dose of Propofol That Caused Loss of Consciousness in 95% (ED95) of Obese and Non-obese Children — 2; 2.125 mg/kg
N/A N=264 School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Overweight · Obesity
Primary: Child Body Mass Index (BMI) — 1.6; 1.5; 1.7; 1.6 units on a scale
N/A N=39 Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
Pseudohypoparathyroidism · Albright Hereditary Osteodystrophy
Primary: Intelligence Quotient — 85.9; 104.3; 103.2 units on a scale
N/A N=59 Improving Parent-Child Interactions to Enhance Child Health
Child Obesity
Primary: Change in Child Body Mass Index (BMI) Percentile — 3.66; 1.74; 1.12; 0.88 percentile — p=.73
N/A N=226 The Resource Information Program for Parents on Lifestyle and Education
Pediatric Obesity
Primary: Feasibility (Parents' Interest in the SBIRT.) — 84.3; NA; NA; NA percentage of parents
N/A N=58,364 Dissemination and Implementation of Improving Pediatric Obesity Practice Using Prompts
Obesity, Childhood
Primary: Mean Change in BMI as Percentage of 95th Percentile — -0.60; -0.34 percentage — p=<0.0001
Phase 3 N=130 A Primary Care Behavioral Approach for Addressing Childhood Overweight
Obesity
Primary: BMI Z-score(for Gender and Age)at 6-months — -0.129; 0.001 Z-score
N/A N=1,136 Addressing Obesity in Early Care and Education Settings
Obesity
Primary: Child BMI Z-score — 0.40; 0.43; 0.31; 0.48 Z-score — p=0.003
Phase 2 N=12 GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
Obesity, Morbid
Primary: Change in Body Mass Index (BMI) — -0.9; 0.84 change in kg/m^2
N/A N=61 Healthy Weight for Teens
Obesity
Primary: Number of Participants With Successful Implemenmtation of BPE (Bundle of Program Enhancements) in Existing Multi-component PWM Programs — 20; 12 Participants
Phase 1 N=71 Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study
Obesity · GERD
Primary: Pantoprazole Apparent Oral Clearance — 0.42; 0.29; 0.23 L/hr/kg
N/A N=418 Parent Involvement in Adolescent Obesity Treatment
Pediatric Obesity
Primary: Body Mass Index (BMI) Change — 1.51; 0.91 kg/m^2
Phase 2 N=100 Metformin to Treat Obesity in Children With Insulin Resistance
Hyperinsulinemia · Obesity
Primary: Changes in Body Weight as Determined by Body Mass Index-standard Deviation Score (BMI-SDS). — -0.11; -0.07 Units on a scale
N/A N=237 Habituation to Food as a Risk Factor for Pediatric Obesity
Obesity in Children
Primary: Change in zBMI — -0.048; 0.013; 0.011 z-score — p=0.051
N/A N=342 Translational Investigation of Growth and Everyday Routines in Kids
Childhood Obesity
Primary: Objective 1 Primary Outcome: Change in Minutes of Sedentary Behavior, Light Physical Activity, and Moderate-to-vigorous Physical Activity — 21.4; 7.6; 1.0 Minutes…
N/A N=184 NOURISH: Nourishing Our Understanding of Role Modeling to Improve Support and Health
Pediatric Obesity
Primary: Child BMI — 98.47; 97.86; 98.19; 97.86 percentile — p=.008
N/A N=1,010 Primary Care Pediatrics Learning Activity and Nutrition With Families
Pediatric Obesity
Primary: Body Composition Measures of Targeted Child. Percent Change Over the Median BMI — 10.2; 3.4 percent change — p=<0.05
Phase 1 N=22 PED NEONAT 20-000599 Fetal Body Composition
IUGR · Gestational Diabetes · Pregnancy Related
Primary: Maternal Visceral Adipose Tissue Volume — 97593; 169626; 96787 mm3
Phase 3 N=26 Dexmedetomidine to Treat Bariatric Surgery-associated Pain
Obesity
Primary: Pain Scores (Numerical Rating Scale 0-10) Using the Faces Pain Scale-Revised — 5; 3.4 Units on a scale
N/A N=61 Endothelial Dysfunction in Obese Children
Obesity · Atherosclerosis
Primary: Change From Baseline in Reactive Hyperemia Index at 5 and 10 Months — 1.9; 1.5; 2.01; 1.55 arbitrary units — p=<0.05